The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines

Toxicology in Vitro

Volumn 43, Issue , 2017, Pages 69-75

  Zielińska Przyjemska, Małgorzata ^a   Kaczmarek, Mariusz ^a   Krajka Kuźniak, Violetta ^a   Łuczak, Michał ^b   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b BROWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle; Human T98G glioblastoma cells; Rat C6 glioma cells; Stilbene derivatives; Tannic acid

Indexed keywords

3,5,4' TRIMETHOXYSTILBENE; CAMPTOTHECIN; CASPASE 3; PHENOL DERIVATIVE; PROTEIN P53; PTEROSTILBENE; RESVERATROL; TANNIN; UNCLASSIFIED DRUG; 3,4',5-TRIMETHOXYSTILBENE; PHARMACEUTICAL VEHICLES AND ADDITIVES; STILBENE DERIVATIVE; TANNIN DERIVATIVE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; G2 PHASE CELL CYCLE CHECKPOINT; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IC50; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NONHUMAN; PROTEIN CLEAVAGE; RAT; ANIMAL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; TUMOR CELL LINE;

ADJUVANTS, PHARMACEUTIC; ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GLIOMA; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; RATS; STILBENES; TANNINS;

EID: 85020738336     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2017.06.004     Document Type: Article

References (37)

1. Aldawsari, F.S., Velázquez-Martínez, C.A., 3,4′,5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency. Investig. New Drugs 33 (2015), 775–786.
2. Baer-Dubowska, W., Szaefer, H., Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans. Expert Opin. Drug Metab. Toxicol. 9 (2013), 927–941.
3. Berger, B., Capper, D., Lemke, D., Pfenning, P.N., Platten, M., Weller, M., von Deimling, A., Wick, W., Weiler, M., Defective p53 antiangiogenic signaling in glioblastoma. Neuro-Oncology 12 (2010), 894–907.
4. Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G., Franceschi, C., New method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197 (1993), 40–45 (1993).
5. Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., Henson, P.M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992), 2207–2216.
6. Fossati, G., Ricevuti, G., Edwards, S.W., Walker, C., Dalton, A., Rossi, M.L., Neutrophil infiltration into human gliomas. Acta Neuropathol. 98 (1999), 349–354.
7. Gagliano, N., Aldini, G., Colombo, G., Rossi, R., Colombo, R., Gioia, M., Milzani, A., Dalle-Donne, I., The potential of resveratrol against human gliomas. Anti-Cancer Drugs 21 (2010), 140–150.
8. Gajate, C., Santos-Beneit, A.M., Macho, A., Lazaro, M., Hernandez-De Rojas, A., Modolell, M., Munoz, E., Mollinedo, F., Involvement of mitochondria and caspase-3 in ET-18- OCH3 induced apoptosis of human leukemia cells. Int. J. Cancer 86 (2000), 208–218.
9. Grobben, B., De Deyn, P.P., Slegers, H., Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310 (2002), 257–270.
10. Ignatowicz, E., Balana, B., Vulimiri, S.V., Szaefer, H., Baer-Dubowska, W., The effect of plant phenolics on the formation of 7,12-dimethylbenz[a]anthracene-DNA adducts and TPA-stimulated polymorphonuclear neutrophils chemiluminescence in vitro. Toxicology 189 (2003), 199–209.
11. Jaks, V., Jõers, A., Kristjuhan, A., Maimets, T., P53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with campthothecin. Oncogene 20 (2001), 1212–1219.
12. Jiang, H., Zhang, L., Kuo, J., Kuo, K., Gautam, S.C., Groc, L., Rodriguez, A.I., Koubi, D., Hunter, T.J., Corcoran, G.B., Seidman, M.D., Levine, R.A., Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4 (2005), 554–561.
13. Kapetanovic, I.M., Muzzio, M., Huang, Z., Thompson, T.N., McCormick, D.L., Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Kapet Cancer Chemother. Pharmacol. 68 (2011), 593–601.
14. Kuršvietienė, L., Stanevičienė, I., Mongirdienė, A., Bernatonienė, J., Multiplicity of effects and health benefits of resveratrol. Medicina (Kaunas) 52 (2016), 148–155.
15. Levine, A.J., Oren, M., The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9 (2009), 749–758.
16. Lin, H.-S., Ho, P.C., A rapid HPLC method for the quantification of 3,5,4′-trimethoxy- (TMS) in rat plasma and its application in pharmacokinetic study. J. Pharm. Biomed. Anal. 49 (2009), 387–392.
17. Lin, H.-S., Yue, B.-D., Ho, P.C., Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed. Chromatogr. 23 (2009), 1308–1315.
18. Lin, H., Xiong, W., Zhang, X., Liu, B., Zhang, W., Zhang, Y., Cheng, J., Huang, H., Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol. Rep. 26 (2011), 925–930.
19. Michels, G., Wätjen, W., Weber, N., Niering, P., Chovolou, Y., Kampkötter, A., Proksch, P., Kahl, R., Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology 225 (2006), 173–182.
20. Mikstacka, R., Przybylska, D., Rimando, A.M., Baer-Dubowska, W., Inhibition of human recombinant cytochromem P450 CYPA1 and CYP1B1 by trans-resveratrol metyl ethers. Mol. Nutr. Food Res. 51 (2007), 517–524.
21. Moses, K., Brandau, S., Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin. Immunol., 28, 2016, 197-196.
22. Otsuki, Y., Li, Z., Shibata, M.A., Apoptotic detection methods-from morphology to gene. Prog. Histochem. Cytochem. 38 (2003), 275–339.
23. Ravera, S., Aluigi, M.G., Calzia, D., Ramoino, P., Morelli, A., Panfoli, I., Evidence for Ectopic Aerobic ATP production on C6 glioma cell plasma membrane. Cell. Mol. Neurobiol. 31 (2011), 313–321.
24. Scott, E., Steward, W.P., Gescher, A.J., Brown, K., Resveratrol in human cancer chemoprevention – choosing the ‘right’ dose. Mol. Nutr. Food Res. 56 (2012), 7–13.
25. Sun, Z., Shi, S., Li, H., Shu, X.-H., Chen, X.-Y., Kong, Q.-Y., Liu, J., Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells. Cancer Chemother. Pharmacol. 72 (2013), 965–973.
26. Timitryasova, T.M., Chen, B., Haghighat, P., Fodor, I., Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induce apoptosis. Int. J. Oncol. 14 (1999), 845–854.
27. Van Meir, E.G., Hadjipanayis, C.G., Norden, A.D., Shu, H.K., Wen, P.Y., Olson, J.J., Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin. 60 (2010), 166–193.
28. Vogelstein, B., Kinzler, K.W., P53 function and dysfunction. Cell 70 (1992), 523–526.
29. Wang, Q., Xu, J., Rottinghaus, G.E., Simonyi, A., Lubahn, D., Sun, G.Y., Sun, A.Y., Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958 (2002), 439–447.
30. Wang, D.G., Hang, T.J., Wu, C.Y., Liu, W.Y., Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J. Chromatogr. B829 (2005), 97–106.
31. Wang, T.T.Y., Schoene, N.W., Kim, Y.S., Mizuno, C.S., Rimando, A.M., Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol. Nutr. Food Res. 54 (2010), 335–344.
32. Wang, G., Dai, F., Yu, K., Jia, Z., Zhang, A., Huang, Q., Kang, Ch., Jiang, H., Pu, P., Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways. Int. J. Oncol. 46 (2015), 1739–1747.
33. Weng, C.J., Yang, Y.T., Ho, C.T., Yen, G.C., Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells. J. Agric. Food Chem. 57 (2009), 5235–5243.
34. Xue, S., Xiao-Hong, S., Lin, S., Jie, B., Li-Li, W., Jia-Yao, G., Shun, S., Pei-Nan, L., Mo-Li, W., Qian, W., Xiao-Yan, C., Qing-You, K., Peng, Z., Hong, L., Jia, L., Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas. Oncotarget 7 (2016), 75790–75799.
35. Zhang, W., Fei, Z., Zhen, H.N., Zhang, J.N., Zhang, X., Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J. Neuro-Oncol. 81 (2007), 231–241.
36. Zhang, W.B., Wang, Z., Shu, F., Jin, Y.H., Liu, H.Y., Wang, Q.J., Yang, Y., Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J. Biol. Chem. 285 (2010), 40461–40471.
37. Zielińska-Przyjemska, M., Ignatowicz, E., Krajka-Kuźniak, V., Baer-Dubowska, W., Effect of tannic acid, resveratrol and its derivatives, on oxidative damage and apoptosis in human neutrophils. Food Chem. Toxicol. 84 (2015), 37–46.